CYTOKINETICS, INCORPORATED Shareholders' Equity
CYTOKINETICS, INCORPORATED (CYTK) had Shareholders' Equity of -$173.49 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent -$173.49M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$826.57M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$659.63M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$521.12M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$173.49M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$826.57M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | -$659.63M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | -$521.12M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | -$368.72M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | -$266.41M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | -$135.37M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | -$13.91M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $108.55M 10-Q · filed 2025-11-05 | |
| 2024-03-31 | -$396.16M 10-Q · filed 2025-11-05 | |
| 2023-12-31 | -$386.32M 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$438.80M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | -$333.12M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | -$229.02M 10-Q · filed 2024-11-07 | |
| 2022-12-31 | -$107.90M 10-K · filed 2026-02-26 | |
| 2022-09-30 | -$15.98M 10-Q · filed 2023-11-03 | |
| 2022-06-30 | $111.41M 10-Q · filed 2023-11-03 | |
| 2022-03-31 | $116.26M 10-Q · filed 2023-11-03 | |
| 2021-12-31 | $243.86M 10-K · filed 2025-02-27 | |
| 2021-09-30 | $249.02M 10-Q · filed 2022-11-04 | |
| 2021-06-30 | $16.49M 10-Q · filed 2022-11-04 | |
| 2021-03-31 | $67.85M 10-Q · filed 2022-11-04 | |
| 2020-12-31 | $113.38M 10-K · filed 2024-02-28 | |
| 2020-09-30 | $149.60M 10-Q · filed 2021-11-05 | |
| 2020-06-30 | -$78.08M 10-Q · filed 2021-11-05 | |
| 2020-03-31 | -$45.71M 10-Q · filed 2021-11-05 | |
| 2019-12-31 | -$10.94M 10-K · filed 2023-03-01 | |
| 2019-09-30 | -$19.87M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | -$4.90M 10-Q · filed 2020-11-06 | |
| 2019-03-31 | $3.37M 10-Q · filed 2020-11-06 | |
| 2018-12-31 | $25.93M 10-K · filed 2022-02-25 | |
| 2018-09-30 | $52.07M 10-Q · filed 2019-11-01 | |
| 2018-06-30 | $75.17M 10-Q · filed 2019-11-01 | |
| 2018-03-31 | $99.60M 10-Q · filed 2019-11-01 | |
| 2017-12-31 | $109.84M 10-K · filed 2021-02-26 | |
| 2017-09-30 | $147.04M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $175.00M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $95.38M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $94.36M 10-K · filed 2019-03-07 | |
| 2016-09-30 | $84.72M 10-Q/A · filed 2016-12-15 | $83.25M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $48.75M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $57.91M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $68.59M 10-K · filed 2018-03-05 | |
| 2015-09-30 | $67.30M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $74.86M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $84.15M 10-Q · filed 2015-05-04 | |
| 2014-12-31 | $92.06M 10-K · filed 2018-03-05 | |
| 2014-09-30 | $73.63M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $78.70M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $86.18M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $54.44M 10-K · filed 2017-03-06 | |
| 2013-09-30 | $39.75M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $51.99M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $58.43M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $70.08M 10-K · filed 2016-03-03 | |
| 2012-09-30 | $80.60M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $89.98M 10-Q · filed 2012-08-06 | |
| 2012-03-31 | $42.01M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $48.18M 10-K · filed 2015-03-06 | |
| 2011-09-30 | $56.74M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $66.65M 10-Q · filed 2011-08-04 | |
| 2010-12-31 | $70.52M 10-K · filed 2014-03-07 | |
| 2009-12-31 | $101.43M 10-K · filed 2013-03-15 | |
| 2008-12-31 | $49.77M 10-K · filed 2013-03-15 | |
| 2007-12-31 | $99.92M 10-K · filed 2013-03-15 | |
| 2006-12-31 | $106.31M 10-K · filed 2013-03-15 | |
| 2005-12-31 | $73.56M 10-K · filed 2013-03-15 | |
| 2004-12-31 | $107.56M 10-K · filed 2013-03-15 | |
| 2003-12-31 | -$92.03M 10-K · filed 2013-03-15 | |
| 2002-12-31 | -$60.59M 10-K · filed 2013-03-15 | |
| 2001-12-31 | -$37.35M 10-K · filed 2013-03-15 | |
| 2000-12-31 | -$21.82M 10-K · filed 2013-03-15 | |
| 1999-12-31 | -$9.12M 10-K · filed 2013-03-15 | |
| 1998-12-31 | -$2.00M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |